Family Office Briefing on research bySavills·May 10, 2024
San Francisco Bay Area Q1 2024 Life Sciences Market Report
San Francisco Bay Area life sciences market shows robust investment activity in Q1 2024 — family offices should consider co-GP opportunities with established operators.
Key Metrics
| Metric | Value |
|---|---|
| Q1 2024 Capital Invested | 2.6Billion USD |
| Q1 2024 Deal Count | 86Deals |
| Alumis Deal Size | 259.0Million USD |
| Freenome Deal Size | 254.0Million USD |
| BioAge Deal Size | 194.3Million USD |
| Cellanome Deal Size | 150.0Million USD |
| Eyconis Deal Size | 150.0Million USD |
Metrics extracted from the source report and independently fact-checked. Method →
Full report
Savills
Building a thesis around San Francisco? Share it confidentially with the Thesis Exchange — we pair you anonymously with family offices running adjacent life science strategies.
Peer Network · By Invitation
The Thesis Exchange
Share an investment thesis in confidence. We pair you anonymously with up to two other family offices running adjacent strategies. Reviewed by Gallium's editorial team. No vendor pitch.